Clinical Trials in California

Showing 2881-2900 of 11,359 trials

Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations

NCT06655064

The purpose of this observational research registry is to understand the real-world use of Illuccix PET/CT in prostate cancer, and how results from this testing impact patient's treatment and prostate cancer journey over time. It will follow subjects and the diagnostic testing and therapy they receive for their prostate cancer. Subjects will not be administered any medical diagnostic testing or therapy that they would not have normally undergone outside of participation in the registry.

Prostate Cancer (Adenocarcinoma)

Telix Pharmaceuticals (Innovations) Pty Limited120 participantsStarted Jan 2025

Fresno, California, United States • Fresno, California, United States • Grand Junction, Colorado, United States +6 more locations

Active Not RecruitingPhase 344 miles

SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)

NCT06140303

The purpose of this study is to assess the safety and efficacy of SkinTE for treatment of Wagner grade 1 diabetic foot ulcers.

Diabetic Foot

PolarityTE100 participantsStarted Feb 2024

Mesa, Arizona, United States • Castro Valley, California, United States • Fresno, California, United States +20 more locations

Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations

SkinTE® for the Treatment of Wagner 1 Diabetic Foot Ulcers (COVER DFUS II)

Find Trials by Condition in California

Technology and Family Thriving Study

ALTO-100 in Bipolar Disorder With Depression (BD-D)

Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis

Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction

MitraClip EXPAND G4 Study

Performance Evaluation of the AMIA APD Solution Generation System in Patients End Stage Renal Disease (ESRD)

Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study

A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD)

Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid Leukemia

Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma

A Study to Compare Nighttime Aligners to Daytime Aligners

A Study of JNJ-55308942 in the Treatment of Bipolar Depression

Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer

Ceramic-on-Ceramic (COC) 36mm Acetabular Bearing Insert Post Approval Study-New Subjects (COC36mmPAS)